Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...
Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...